INTRODUCTION
Transfer RNAs (tRNAs) are noncoding RNAs (ncRNAs) with lengths of 60-to 90-nucleotide (nt) that play central roles as adapter molecules in the translational machinery. Although tRNA molecules are stable and abundant, the expression profiles of individual tRNAs vary dynamically among different cells and tissues (Dittmar et al. 2006; Pavon-Eternod et al. 2009; Zhou et al. 2009; Mahlab et al. 2012 ) and this variation has been implicated in the translational regulation of mRNA expression (Gingold et al. 2014) , animal development Rideout et al. 2012; Schmitt et al. 2014) , and disease (Daly et al. 2005; Pavon-Eternod et al. 2010; Zhou et al. 2012; Clarke et al. 2016) . Accumulating evidence regarding tRNA-derived ncRNAs has further increased the complexity of tRNA biology. In many organisms, tRNAs are not always end products but are processed further into smaller ncRNAs, many of which are known to be functional molecules with roles in various biological processes beyond translation (Garcia-Silva et al. 2012; Gebetsberger and Polacek 2013; Anderson and Ivanov 2014; Saikia and Hatzoglou 2015; Shigematsu and Kirino 2015; Telonis et al. 2015; Diebel et al. 2016) . These tRNA-derived ncRNAs are in general classified into two groups: tRNA halves that range either from the 5 ′ -end to the anticodon loop (5 ′ -half) or from the anticodon loop to the 3 ′ -end (3 ′ -half) of a mature tRNA, and shorter tRNA-derived fragments (tRFs) that originate from various regions of mature tRNAs or their precursor transcripts (pre-tRNAs).
To date, two distinct classes of tRNA halves have been identified: tRNA-derived stress-induced RNAs (tiRNAs) (Thompson et al. 2008; Fu et al. 2009; Hsieh et al. 2009; Yamasaki et al. 2009; Saikia et al. 2012 ) and sex hormone-dependent tRNA-derived RNAs (SHOT-RNAs) . Although both tiRNAs and SHOT-RNAs are produced from mature tRNAs via angiogenin (ANG)-mediated cleavage of the anticodon loop (Fu et al. 2009; Yamasaki et al. 2009; , the molecular factors that trigger their production are different. The expression of tiRNAs is triggered by a variety of stress stimuli, including oxidative stress, heat/cold shock, and UV irradiation (Shigematsu et al. 2014; Saikia and Hatzoglou 2015) . The accumulation of tiRNAs has been implicated in stress granule formation (Emara et al. 2010; Lyons et al. 2016) , translational regulation (Yamasaki et al. 2009; Ivanov et al. 2011) , and the pathogenesis of neurodevelopmental disorders (Blanco et al. 2014) . In contrast, the expression of SHOT-RNAs is promoted by signaling pathways associated with sex hormones (e.g., estrogen and androgen) and their receptors (e.g., estrogen receptor [ER] and androgen receptor [AR] ). SHOT-RNAs are specifically expressed in ER-or AR-positive breast and prostate cancers and have functional significance in cell proliferation .
Because ANG leaves a 2 ′ ,3 ′ -cyclic phosphate (cP) on its 5 ′ -cleavage products (Shapiro et al. 1986 ), ANG-generated 5 ′ -tRNA halves contain a cP at the 3 ′ -end . These cP-containing RNAs cannot be captured accurately by standard RNA-seq methods because they are not ligated to a 3
′ -adapter during library preparation procedure. We circumvented the issue by developing a cP-RNA-seq method that can exclusively sequence cP-containing RNAs (Honda et al. , 2016 and used this method to determine the expression repertoire of 5 ′ -SHOT-RNAs (5 ′ -tRNA halves) in human BT-474 ER-positive breast cancer cells; accordingly, we identified eight cytoplasmic (cyto) tRNA species as the major sources of SHOT-RNAs . Although 5 ′ -SHOTRNAs from cyto tRNA LysCUU and tRNA HisGUG were particularly enriched, the molecular mechanism by which specific tRNAs are selectively cleaved for SHOT-RNA production remains elusive.
Among all species of tRNAs, tRNA HisGUG is unique in that it contains an additional guanosine residue at the −1 position (G −1 ) of its 5 ′ -end (Sprinzl et al. 1998 ). This G −1 residue is conserved across phyla and has been observed in bacteria (Singer and Smith 1972; Orellana et al. 1986 ), yeast (Keith and Pixa 1984) , fruit fly (Altwegg and Kubli 1980) , and mammals (Boisnard and Petrissant 1981; Rosa et al. 1983) . In Escherichia coli, this G −1 residue is genome-encoded, and anomalous RNase P cleavage of pre-tRNA HisGUG between positions −1 and −2 yields G −1 -containing tRNA HisGUG (Orellana et al. 1986; Burkard et al. 1988) . In yeast, G −1 is not derived from the genomic sequence; instead, tRNA His guanylyltransferase (Thg1) post-transcriptionally adds this residue to the 5 ′ -end (Gu et al. 2003) . The conservation of G −1 residue addition via different mechanisms in different organisms implies the functional significance of the G −1 residue. Indeed, the G −1 residue is a critical determinant for the aminoacylation of tRNA HisGUG by the cognate histidyl-tRNA synthetase (HisRS) in both E. coli (Himeno et al. 1989 ) and yeast (Rudinger et al. 1994; Rosen et al. 2006) . In yeast, the loss of this G −1 residue consequent to the depletion of Thg1 or its polymerase activity causes a severe reduction in the tRNA HisGUG aminoacylation levels, resulting in growth impairment (Gu et al. 2005; Jackman and Phizicky 2008; Preston and Phizicky 2010) . The G −1 residue is also implicated in post-transcriptional nucleotide modification because yeast lacking this residue has been shown to acquire additional 5-methylcytidine (m 5 C) modifications (Gu et al. 2005; Preston et al. 2013) , although a biological role for the interplay between the absence of G −1 and the presence of m 5 C is unknown. In contrast to the presence and significance of G −1 in these studies, some organisms such as α-proteobacteria (Wang et al. 2007; Jackman et al. 2012) , Acanthamoeba (Rao et al. 2013) , and Trypanosoma (Rao and Jackman 2015) lack G −1 . HisRS does not require G −1 for aminoacylation in these species.
Despite the advent of next-generation sequencing (NGS) technologies and their widespread use in RNA-seq for transcriptome analyses, the −1 nucleotide of tRNA HisGUG has not been investigated in RNA-seq-based studies. This could be partly attributable to the expectation that tRNA HisGUG contains post-transcriptional modifications that would interfere with reverse transcription (Kellner et al. 2010 ), such as a 1-methyl-guanosine at nucleotide position 37 (m 1 G 37 ) (Boisnard and Petrissant 1981) (nucleotide position [np] is based on the tRNA numbering system [Sprinzl et al. 1998 ]). Indeed, human and Bombyx 3 ′ -haves of cyto tRNA HisGUG , possessing G 37 (likely modified to m 1 G 37 ), could not be amplified by RT-PCR despite being successfully detected by Northern blot . The presence of the RT-interfering modification would lead to underrepresentation and bias in the tRNA HisGUG sequence information generated from RNA-seq data. While analyzing a cP-RNA-seq library of 5 ′ -SHOT-RNAs from BT-474 cells , we reasoned that this library would be useful for observing the −1 nucleotide on human cyto tRNA HisGUG 
RESULTS AND DISCUSSION
The majority of 5 ′ -SHOT-RNA HisGUG molecules lack the −1 nucleotide The human nuclear genome contains 11 cyto tRNA HisGUG genes that encode three different isodecoders (Supplemental Fig. S1 ). In the 5 ′ -SHOT-RNA sequence repertoire of BT-474 cells, which was previously identified using cP-RNAseq (Honda et al. , 2016 , 5
′ -SHOT-RNA HisGUG sequences constituted approximately 7.9 million reads, comprising 27.5% of the total reads of 5 ′ -SHOT-RNAs. Accordingly, 5
′ -SHOT-RNA HisGUG is the second most abundant 5
′ -SHOT-RNA species in BT-474 cells, after 5
HisGUG sequences corresponded to a single major isodecoder of cyto tRNA HisGUG ( Fig. 1A ) that is encoded by nine of the 11 genes (Supplemental Fig. S1 ), suggesting that this isodecoder is the major cyto tRNA HisGUG molecule expressed in the cells. Almost all (98%) of the 5 ′ -SHOT-RNA HisGUG had a 3 ′ -terminal position at np 34 ( Fig. 1B) , indicating a focal pattern of ANG cleavage between the anticodon first (G 34 ) and second (U 35 ) letters during the production of 5 ′ -SHOT-RNA HisGUG . In contrast to the consistent 3 ′ -termini, six 5
′ -terminal variations were observed among the sequenced 5
′ -SHOT-RNA HisGUG (Fig. 1C) . In contrast to previous reports of a major presence of the 5 ′ -terminal G −1 in tRNA HisGUG , a majority (>75%) of 5 ′ -SHOT-RNA HisGUG lacked the −1 nucleotide and initiated at np 1 (G 1 ) (Fig.   1D ). The second most abundant class (>12%) of 5 ′ -SHOT-RNA HisGUG contained the −1 nucleotide; here, both guanosine (G −1 : 44.3%) and uridine (U −1 : 44.2%) were frequently present at the −1 nucleotide. The other two nucleotides (A −1 : 9%; C −1 : 3%) were also detected as minor −1 nucleotide species, and a 5 ′ -SHOT-RNA HisGUG initiating from np 2 (C 2 : 11%) was also identified.
Experimental validation of the predominant expression of 5
′ -SHOT-RNA HisGUG lacking the −1 nucleotide
Because our cP-RNA-seq scheme includes several chemical and enzymatic RNA treatments (Honda et al. , 2016 , unexpected variations of the 5 ′ -termini of 5 ′ -SHOT-RNA HisGUG might have resulted from undesired procedural RNA damage. To exclude this possibility and confirm that our cP-RNA-seq results reflect the cellular state of RNA expression, we conducted a primer extension assay for 5 ′ -SHOT-RNA HisGUG . In this assay, a radiolabeled DNA primer complementary to np 6−25 of cyto tRNA HisGUG ( Fig. 2A ) was specifically hybridized to 5 ′ -SHOT-RNA HisGUG present in gel-purified small RNA fractions (20−50 nt) from BT-474 cells; subsequently, reverse transcription was carried out from the primer. When using synthetic tRNA HisGUG initiating from G 1 as a template, the 5-nt primer extension was detected as a 25-nt band (Fig.  2B) . In contrast, the use of synthetic tRNA HisGUG containing G −1 yielded an additional extension of 1 nt and a 26-nt band that was clearly distinct from the above-mentioned 25-nt band. An equal mix of these two synthetic tRNAs yielded two bands of equal abundance, indicating the ability of this assay to estimate the presence or absence of the −1 nucleotide. By performing reactions using dideoxynucleotides, we confirmed that the reverse transcription was correctly run on tRNA HisGUG in both synthetic RNA and cellular RNA samples (Supplemental Fig. S2 ). Analyses of BT-474 small RNA fractions revealed the marked and more abundant presence of the 25-nt band in comparison with the 26-nt band (Fig. 2B) . Quantification of the band intensities suggested that ∼70% of the 5 ′ -SHOT-RNA HisGUG lacks the −1 nucleotide (Supplemental Fig. S3 ), which is consistent with the cP-RNA-seq-based analyses shown in Figure 1 . These results indicate that the majority of the 5 ′ -SHOT-RNA HisGUG molecules expressed in BT-474 cells lack the −1 nucleotide and initiate from G 1 . In the primer extension assay, we did not observe a clear 24-nt band corresponding to 5 ′ -SHOT-RNA HisGUG initiating from C 2 ; therefore, the presence of such RNA in cP-RNA-seq data might result from undesired procedural RNA damage. ′ -terminal variant of mature cyto tRNA HisGUG containing G −1 , U −1 , A −1 , C −1 , or G 1 as the 5 ′ -terminal nucleotide. We focused on a single major isodecoder encoded by nine of 11 genes in the human genome (Supplemental Fig. S1 ).
In the developed method, mature tRNA fractions (70−90 nt) were first gel-purified from total RNA, after which an acceptor-stem disrupter (AS-disrupter), a DNA oligo complementary to np 55−76 (3 ′ -end) of the cyto tRNA HisGUG , was hybridized to the purified fractions ( Fig. 3A,B ; Supplemental Fig. S4 ). Subsequently, a DNA/RNA chimeric 5 ′ -adapter was ligated to the 5 ′ -ends of mature tRNA HisGUG , and the ligation product was amplified and quantified by TaqMan qRT-PCR to eventually generate an 86-(tRNA starting from G 1 ) or 87-bp cDNA (tRNA containing −1 nucleotide). The AS-disrupter was utilized to disrupt mature tRNA HisGUG structure; this disruption was expected to enhance the accessibility of the adapter, primer, and enzymes to the tRNA and thereby increase the reaction efficiencies following hybridization. In addition, dimethyl sulfoxide (DMSO) and polyethylene glycol (PEG) 8000, both of which enhance RNA ligation efficiency, were added to the adapter ligation reaction. Indeed, the combined inclusion of the AS-disrupter hybridization step and addition of PEG/ DMSO to the ligation reaction increased the detection efficiency of synthetic tRNA HisGUG with G −1 by more than 95-fold and prevented the synthesis of nonspecific cDNA bands (Fig. 3C) . The TaqMan probe was designed to target the boundary of the adapter and the 5 ′ -end of mature tRNA HisGUG , thus allowing an exclusive analysis of the tRNA 5 ′ -end in the ligation product. Indeed, we were unable to detect an amplification signal in the absence of T4 RNA ligase (Fig. 3C) . Because the TaqMan probe has a single-nucleotide resolution (Ranade et al. 2001; , our design scheme was expected to distinctively quantify each 5
′ -terminal variant of tRNA HisGUG without crossreactivity with other variant species. We confirmed the exclusive specificity of our TaqMan probes to quantify perfectly matched target sequences without cross-reactivity from other variants (Supplemental Table S1 ). To examine the quantification ability, our method was applied to different amounts of synthetic mature tRNA HisGUG (0.1-100 fmol). To mimic tRNA quantification using a total tRNA fraction, an E. coli tRNA fraction was mixed with synthetic RNA as a carrier; we confirmed that the E. coli tRNA fraction did not yield an amplification signal in our system. For all five synthetic 5 ′ -terminal variants, the quantifications demonstrated clear linearity between the log of tRNA input and the Ct value (Supplemental Fig. S5 ), indicating that this method has a dynamic range of at least three orders of magnitude, and discriminately quantifies the 5 ′ -terminal variants. We further validated our method by quantifying a mixture of different synthetic tRNA variants. Since 5 ′ -SHOT-RNAs HisGUG starting from G 1 , G −1 , and U −1 were mainly detected (Fig. 1D) , corresponding mature synthetic tRNAs HisGUG were mixed at several different ratios and subjected to the method with an E. coli tRNA carrier. The amount of each detected tRNA was calculated based on the standard curves (Supplemental Fig. S5 ). As shown in Figure 3D , the resultant relative abundances of detected tRNAs well reflected those of the tRNAs added to the reactions, allowing us to conclude that our method can estimate the relative abundance of 5 ′ -terminal variants of mature tRNA HisGUG .
The majority of the mature tRNA HisGUG molecules contain the −1 nucleotide Given the high specificity and quantification ability of our TaqMan qRT-PCR method, we utilized this method to determine the relative abundances of the 5 ′ -terminal variants of endogenous mature cyto tRNA HisGUG expressed in BT-474 cells. Using our synthetic tRNA results as standards, we determined the relative abundances of the five potential 5 ′ -terminal variants of tRNA HisGUG . In contrast to the 5 ′ -terminal variations of 5 ′ -SHOT-RNA HisGUG , which were dominated by G 1 (Fig. 1C) , ∼60% of the mature tRNA HisGUG contained G −1 as a 5 ′ -terminal nucleotide (Fig. 4A) . A significant proportion of tRNAs contained U −1 (∼20%), and a similar . An assay without template RNA was also performed as a negative control experiment.
proportion lacked the -1 nucleotide. We could not detect amplification signals from tRNAs containing A −1 and C −1 , likely because those tRNA species were not expressed at sufficient levels to allow detection by our system. The predominance of the -1 nucleotide-containing tRNA HisGUG was validated by a primer extension assay using the mature tRNA fractions from BT-474 cells. In contrast to the 5 ′ -SHOT-RNA HisGUG analyses, in which the 25-nt band was more abundant than the 26-nt band (Fig. 2B) , mature tRNA analyses revealed a predominance of the 26-nt band (Fig.  4B) . Because of the low resolution of this method for mature tRNA, no clear band around 25 nt appeared, and thereby it was difficult to estimate the relative abundance of the -1 nucleotide lacking tRNA. However, this result at least validated our TaqMan qRT-PCR result that the -1 nucleotide-containing tRNA HisGUG is the major mature species in BT-474 cells.
Potential mechanisms by which distinct 5
′ -terminal variations are formed in mature cyto tRNA HisGUG molecules and 5 ′ -halves
This study identified the 5 ′ -terminal variations of human mature cyto tRNA HisGUG in BT-474 cells. Although more than half of the tRNAs contained G −1 , substantial amounts of previously unreported mature tRNA species either containing U −1 or lacking the -1 nucleotide were also identified. In earlier studies, mammalian cyto tRNA HisGUG from HeLa cells and sheep liver were analyzed using chromatography, and neither U −1 -containing nor -1 nucleotide-lacking tRNAs were detected (Boisnard and Petrissant 1981; Rosa et al. 1983) . This difference might be attributable to differences in the detection method sensitivities. During the course of this study, an advanced tRNA sequencing method has been reported in which methylations, including m 1 G, were removed from tRNAs via engineered AlkB demethylase prior to reverse transcription, thereby reducing sequencing bias from these methylations (Zheng et al. 2015) . We investigated the -1 nucleotide variations of tRNA HisGUG in the reported less-biased tRNA sequencing data set from HEK293T cells (Supplemental Table S2 ). As a result, we observed a major population of mature tRNA HisGUG containing G −1 (47%), and substantial populations of mature tRNAs containing U −1 (18%) or lacking the -1 nucleotide (30%); these results were similar to the 5 ′ -variations that we observed in mature tRNA from BT-474 cells. These results suggest the universality of the presence of mature tRNA HisGUG containing U −1 or lacking the -1 nucleotide, as well as molecules containing G −1 , among human cultured ′ -variations in mature tRNA and the functional significance remain to be determined. Because Thg1 or a Thg1-like protein (TLP) from Bacillus, archaea and yeast can attach not only to guanosine, but also to uridine, to the −1 position of the tRNA in vitro (Jackman and Phizicky 2006; Rao et al. 2011) , Thg1 might incorporate both G −1 and U −1 into human mature tRNA HisGUG . It will be intriguing to analyze the efficiency of human HisRS aminoacylation toward each mature tRNA HisGUG 5 ′ -variant to determine whether these variations affect the regulation of aminoacylation. Because human Thg1 is associated with cell cycle regulation (Guo et al. 2004) , the biological significance of these 5 ′ -variations in mature tRNA
HisGUG might also include cell growth regulation.
The 5 ′ -terminal variations of 5 ′ -SHOT-RNA HisGUG exhibited a pattern distinct from that of mature tRNA; specifically, 5 ′ -SHOT-RNA HisGUG molecules mostly lack the -1 nucleotide. This inconsistency might be attributable to ANG cleavage activity to generate SHOT-RNAs. ANG might selectively cleave -1 nucleotide-lacking tRNAs, resulting in a considerable accumulation of -1 nucleotide-lacking SHOT-RNA molecules. However, ANG is a small protein, and thus selective cleavage should be facilitated by cofactors. Alternatively, ANG might cleave tRNA irrespective of the 5 ′ -terminal nucleotide; SHOT-RNA lacking the -1 nucleotide might then be more stable within the cells than SHOT-RNA containing G −1 , or an unknown ribonuclease might trim the -1 nucleotide from SHOT-RNAs. The generative mechanism and biological significance of these 5 ′ -terminal variations in mature tRNA
HisGUG molecules 5 ′ -halves remain to be elucidated.
MATERIALS AND METHODS

Bioinformatics analyses of 5
′ -SHOT-RNA
HisGUG
Human cyto tRNA HisGUG sequences were identified using the tRNAscan-SE program (Lowe and Eddy 1997) and are shown in Supplemental Figure S1 . The 5 ′ -SHOT-RNA library was previously obtained by cP-RNA-seq of gel-purified 30-to 50-nt RNAs from BT-474 cells and can be found in the Gene Expression Omnibus Database (GEO accession no. SRX1060214). Reads previously mapped to mature cyto tRNA HisGUG sequences were extracted and used for this study.
Cell culture
BT-474 cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Life Technologies) containing 10% (v/v) FBS.
In vitro synthesis of tRNA HisGUG
Templates for the in vitro synthesis of human cyto tRNA HisGUG (with or without N −1 nucleotide) were prepared by annealing two ssDNAs (5 ′ -GCTTAATACGACTCACTATAGCCGTGATCGTATA GTGGTTAGTACTCTGCGTTGTGGC-3 ′ and 5 ′ -mUmGGTGCC GTGACTCGGATTCGAACCGAGGTTGCTGCGGCCACAACGC -3 ′ ) in a solution containing 10 mM Tris-HCl (pH 8.0) and 20 mM MgCl 2 . After blunting the formed duplex using sequenase (Affymetrix), the resultant dsDNAs were used as templates for transcription with T7 RNA polymerase (New England Biolabs). Synthesized RNAs were gel-purified using denaturing PAGE.
5
′ -End identification of tRNA HisGUG by TaqMan qRT-PCR The sequences of the adapter, AS-disrupter, primers, and TaqMan probes for TaqMan qRT-PCR are shown in Supplemental Table S4 . The 70-to 90-nt RNA fraction, which contained mature tRNAs, was initially gel-purified from total RNA using denaturing PAGE. To ligate the 5 ′ -adapter, to the 5 ′ -end of cyto tRNA HisGUG , 500 ng of the tRNA fraction were incubated with 100 pmol of AS-disrupter in a 4-µL reaction mixture at 90°C for 2 min and subsequently incubated at 37°C. RNA was then added immediately to a ligation reaction mixture (total volume: 10 µL) containing 200 pmol of 5 ′ -adapter, T4 RNA ligase 1 (New England Biolabs), 10% (v/v) DMSO, and 5% PEG8000 and incubated at 37°C for 1 h, followed by an overnight incubation at 4°C. Next, 1 µL of the ligation mixture was subjected to cDNA synthesis with 1 µM of RT primer and SuperScript III (Invitrogen). For TaqMan qPCR quantification, the cDNA product (0.5 µL of the RT mixture) was added to a reaction mixture (total volume: 10 µL) containing 5 µL of qPCR Master Mix (TaKaRa), 0.2 µM each of reverse and forward primers, and 0.1 µM of TaqMan probe. Using a StepOne Plus Real-time PCR machine (Applied Biosystems), the reaction mixture was incubated at 95°C for 20 sec, followed by 40 cycles of 95°C for 1 sec and 65°C for 20 sec.
Primer extension assay
To detect 5 ′ -SHOT-RNA HisGUG , 30-to 50-nt RNAs were first gelpurified from BT-474 total RNA. Subsequently, 50 ng of gel-purified RNA or 0.1 pmol of synthetic tRNA HisGUG were incubated with SuperScript III, the corresponding reaction buffer (Invitrogen), and 0.1 pmol of 5 ′ -32 P-labeled DNA primer (5 ′ -GTACTAACCAC TATACGATC-3 ′ ) at 55°C for 30 min. The reaction mixtures were developed using denaturing PAGE containing 7 M rea and 20% formamide. To analyze mature tRNA HisGUG , 70-to 90-nt mature tRNAs were gel-purified from the total RNAs extracted from BT-474 cells. Gel-purified RNAs (1 µg) were then subjected to a primer extension assay as described above.
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